Prognosis of myopericarditis as determined from previously published reports

Journal of Cardiovascular Medicine

Volumn 15, Issue 12, 2014, Pages 835-839

  Imazio, Massimo ^a   Brucato, Antonio ^b   Spodick, David H ^c   Adler, Yehuda ^d  

^a MARIA VITTORIA HOSPITAL   (Italy)

^b PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^c SAINT VINCENT HOSPITAL   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Diagnosis; Myopericarditis; Prognosis; Therapy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; COLCHICINE; CORTICOSTEROID; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; TROPONIN;

ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; ANGIOCARDIOGRAPHY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONSTRICTIVE PERICARDITIS; DIFFERENTIAL DIAGNOSIS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART TAMPONADE; HOSPITALIZATION; HUMAN; MYOCARDITIS; MYOPERICARDITIS; OUTCOME ASSESSMENT; PERICARDITIS; PROGNOSIS; RECURRENT DISEASE; REVIEW; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW; ADULT; CARDIAC TAMPONADE; COMPLICATION; CONVALESCENCE; DEATH, SUDDEN, CARDIAC; DISEASE COURSE; FEMALE; MALE; MORTALITY; PATHOPHYSIOLOGY; PERICARDITIS, CONSTRICTIVE; PREDICTIVE VALUE;

ADULT; CARDIAC TAMPONADE; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MYOCARDITIS; PERICARDITIS; PERICARDITIS, CONSTRICTIVE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECOVERY OF FUNCTION; RECURRENCE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84916877056     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000082     Document Type: Review

References (25)

1. Spodick DH. Myopericarditis/perimyocarditis. In The pericardium. A comprehensive textbook. New York: Marcel Dekker, Inc.; 1997.
2. Agewall S, Giannitsis E, Jernberg T., Katus H. Troponin elevation in coronary vs. non coronary disease. Eur Heart J 2011; 32:404-411; 3.
3. Bonnefoy E, Godon P, Kirkorian G., et al. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J 2000; 21:832-836.
4. Brandt RR, Filzmaier K, Hanrath P. Circulating cardiac troponin I in acute pericarditis. Am J Cardiol 2001; 87:1326-1328.
5. Imazio M, Spodick DH, Brucato A, et al Controversial issues in the management of pericardial diseases. Circulation 2010; 121:916-928.
6. Imazio M, Cooper LT Management of myopericarditis. Expert Rev Cardiovasc Ther 2013; 11:193-201.
7. Imazio M, Demichelis B, Cecchi E., et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol 2003; 42:2144-2148.
8. Imazio M, Cecchi E, Demichelis B., et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart 2008; 94:498-501.
9. Machado S, Roubille F, Gahide G., et al. Can troponin elevation predict worse prognosis in patients with acute pericarditis? Ann Cardiol Angeiol (Paris) 2010; 59:1-7.
10. Abu Fanne R., Banai S, Chorin U., et al. Diagnostic yield of extensive infectious panel testing in acute pericarditis. Cardiology 2011; 119:134-139.
11. Kobayashi D, Aggarwal S, Kheiwa A., Shah N. Myopericarditis in children: elevated troponin I level does not predict outcome. Pediatr Cardiol 2012; 33:1040-1045.
12. Buiatti A, Merlo M, Pinamonti B., et al. Clinical presentation and long-term follow-up of perimyocarditis. J Cardiovasc Med (Hagerstown) 2013; 14:235-241.
13. Imazio M, Brucato A, Barbieri A., et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter prospective cohort study. Circulation 2013; 128:42-49.
14. Gamaza-Chulian S., Leon-Jimenez J, Recuerda-Nunez M, et al. Cardiac troponin T in acute pericarditis. J Cardiovasc Med 2014; 15:68-72.
15. Imazio M, Brucato A, Adler Y., et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am J Cardiol 2007; 100:1026-1028.
16. Imazio M, Brucato A, Maestroni S., et al. Risk of constrictive pericarditis after acute pericarditis. Circulation 2011; 124:1270-1275.
17. Coronado MJ, Brandt JE, Kim E, et al Testosterone and interleukin-1b increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. Am J Physiol Heart Circ Physiol 2012; 302:H1726-H1736.
18. Elamm C, Fairweather D, Cooper LT Pathogenesis and diagnosis of myocarditis. Heart 2012; 98:835-840.
19. Li Z, Yue Y, Xiong S. Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis. Cardiovasc Pathol 2013; 22:373-382.
20. Meune C, Spaulding C, Mahé I, et al. Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies. Drug Saf 2003; 26:975-981.
21. Seidenberg PH, Haynes J. Pericarditis: diagnosis, management, and return to play. Curr Sports Med Rep 2006; 5:74-79.
22. Durakovid Z, Misigoj Durakovid M, Skavid J, Tomljenovid A. Myopericarditis and sudden cardiac death due to physical exercise in male athletes. Coll Antropol 2008; 32:399-401.
23. Pelliccia A, Corrado D, Bjørnstad HH, et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil 2006; 13:876-885.
24. Pelliccia A, Zipes DP, Maron BJ Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008; 52:1990-1996.
25. Oliveira LP, Lawless CE Making prudent recommendations for return-to-play in adult athletes with cardiac conditions. Curr Sports Med Rep 2011; 10:65-77.